AstraZeneca

R&D

The Alderley Park Discovery Podcast: The journey to accessin...

Episode 3 of the Alderley Park Discovery Podcast covers how to successfully access life science funding and investment, highlighting a range of ways companies can attract investors.

News

Talking vaccines: Industry’s role in protecting the Gavi generation

Austrian safety officials suspend batch of AZ vaccines after...

Austrian health officials have withdrawn a batch of Oxford University/AstraZeneca’s COVID-19 vaccine after two cases of severe coagulation, one of which was fatal.

News

NICE says no to AZ’s Lynparza for prostate cancer

NHS patients in England will not be able to get access to AstraZeneca’s PARP inhibitor Lynparza if they have BRCA-positive advance prostate cancer, according to draft guidance from NICE.

News

Vaccine vial dose flu shot drug needle syringe,medical concept vaccination hypodermic injection treatment disease care hospital prevention immunization illness disease baby child.blue background

Germany backtracks on AZ COVID vaccine age restriction

Germany has decided that AstraZeneca’s COVID-19 vaccine should be approved for use in the over-65s after all, reversing its earlier restriction in that age group.

News

AstraZeneca breathes sigh of relief as court blocks US Symbi...

A US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper competition for the ageing blockbuster.

News

AZ sells stake in Moderna for more than $1billion

AstraZeneca has sold its stake in Moderna for more than $1 billion as the US biotech’s shares soared in value following its coronavirus vaccine breakthrough.

The Alderley Park Discovery Podcast: The journey to accessin...

Austrian safety officials suspend batch of AZ vaccines after...

NICE says no to AZ’s Lynparza for prostate cancer

Germany backtracks on AZ COVID vaccine age restriction

AstraZeneca breathes sigh of relief as court blocks US Symbi...

AZ sells stake in Moderna for more than $1billion

ASCO 2026: AbbVie on ADCs, chemotherapy, and the future of o...

Discover a new era of healthcare panel engagement: Grounded ...

AstraZeneca

Editor's Picks